HQY vs. IQV, RDDT, GIB, CPAY, AER, TOST, RBA, GFL, GRAB, and TRU
Should you be buying HealthEquity stock or one of its competitors? The main competitors of HealthEquity include IQVIA (IQV), Reddit (RDDT), CGI Group (GIB), Corpay (CPAY), Aercap (AER), Toast (TOST), RB Global (RBA), GFL Environmental (GFL), Grab (GRAB), and TransUnion (TRU). These companies are all part of the "business services" industry.
HealthEquity vs. Its Competitors
HealthEquity (NASDAQ:HQY) and IQVIA (NYSE:IQV) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.
HealthEquity presently has a consensus price target of $118.09, suggesting a potential upside of 16.60%. IQVIA has a consensus price target of $226.32, suggesting a potential upside of 37.37%. Given IQVIA's higher possible upside, analysts plainly believe IQVIA is more favorable than HealthEquity.
HealthEquity has a net margin of 9.80% compared to IQVIA's net margin of 8.61%. IQVIA's return on equity of 29.16% beat HealthEquity's return on equity.
99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 89.6% of IQVIA shares are owned by institutional investors. 1.5% of HealthEquity shares are owned by company insiders. Comparatively, 1.6% of IQVIA shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
In the previous week, IQVIA had 7 more articles in the media than HealthEquity. MarketBeat recorded 23 mentions for IQVIA and 16 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.98 beat IQVIA's score of 0.82 indicating that HealthEquity is being referred to more favorably in the media.
IQVIA has higher revenue and earnings than HealthEquity. IQVIA is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.
HealthEquity has a beta of 0.49, suggesting that its share price is 51% less volatile than the S&P 500. Comparatively, IQVIA has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500.
Summary
IQVIA beats HealthEquity on 10 of the 16 factors compared between the two stocks.
Get HealthEquity News Delivered to You Automatically
Sign up to receive the latest news and ratings for HQY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HQY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
HealthEquity Competitors List
Related Companies and Tools
This page (NASDAQ:HQY) was last updated on 7/3/2025 by MarketBeat.com Staff
